History-based breast MR generates high yields

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 9
Volume 32
Issue 9

Screening women with breast MRI based solely on a personal history of breast cancer found malignancies in 12% of the women studied, with a positive predictive value biopsy rate of 39%.

Screening women with breast MRI based solely on a personal history of breast cancer found malignancies in 12% of the women studied, with a positive predictive value biopsy rate of 39%.

A retrospective review of 1699 breast MRI exams performed from 1999 to 2001 yielded 144 women with prior breast cancer who started regular breast MRI screening. Of the 144 women, 31% underwent biopsies prompted by MRI (AJR 2010;195:510-516).

Sixty-one biopsies found 17 carcinomas and one myxoid liposarcoma. The 10 detected by MRI were more likely than the other seven to be ductal carcinoma in situ or node-negative invasive breast cancer <1 cm in size.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.